PL vs REGN · rev $307.7M vs P/E 14, rev $14.34B
Planet Labs PBC (PL) versus Regeneron Pharmaceuticals Inc (REGN) — a side-by-side from cached financials, not a winner call.
Planet Labs PBC (PL) is a aerospace & defense company listed on US.
Regeneron Pharmaceuticals Inc (REGN) is a biotechnology company listed on US.
Latest reported PL revenue for 2026-01-31 was $307.7M. Net income was -$246.9M. Revenue was up 25.9% from 2025-01-31 to 2026-01-31. PL currently screens at market cap $2.08B.
Latest reported REGN revenue for 2025-12-31 was $14.34B. Net income was $4.50B. Revenue was up 1.0% from 2024-12-31 to 2025-12-31. REGN currently screens at market cap $59.10B and trailing P/E 13.9.
PL currently screens at market cap $2.08B. REGN currently screens at market cap $59.10B and trailing P/E 13.9.
Not investment advice. Open the PL and REGN stock pages for the full models.
Not investment advice.